Your browser is no longer supported. Please, upgrade your browser.
BAX Baxter International Inc. daily Stock Chart
Baxter International Inc.
IndexS&P 500 P/E18.50 EPS (ttm)3.36 Insider Own0.10% Shs Outstand546.88M Perf Week-0.08%
Market Cap33.96B Forward P/E24.08 EPS next Y2.58 Insider Trans-95.29% Shs Float543.12M Perf Month1.16%
Income1.85B PEG1.43 EPS next Q0.57 Inst Own86.80% Short Float1.48% Perf Quarter16.69%
Sales10.26B P/S3.31 EPS this Y15.80% Inst Trans-0.65% Short Ratio2.79 Perf Half Y35.42%
Book/sh16.06 P/B3.87 EPS next Y13.46% ROA11.80% Target Price63.43 Perf Year34.69%
Cash/sh5.23 P/C11.88 EPS next 5Y12.97% ROE21.70% 52W Range43.13 - 63.14 Perf YTD40.03%
Dividend0.64 P/FCF27.32 EPS past 5Y18.40% ROI5.30% 52W High-3.83% Beta0.68
Dividend %1.03% Quick Ratio2.10 Sales past 5Y-6.10% Gross Margin38.80% 52W Low40.78% ATR0.74
Employees48000 Current Ratio2.70 Sales Q/Q4.20% Oper. Margin20.30% RSI (14)46.59 Volatility1.13% 1.10%
OptionableYes Debt/Eq0.32 EPS Q/Q-91.90% Profit Margin18.10% Rel Volume1.42 Prev Close62.09
ShortableYes LT Debt/Eq0.32 EarningsJul 26 BMO Payout15.30% Avg Volume2.88M Price60.72
Recom2.50 SMA20-1.05% SMA501.49% SMA20017.51% Volume732,307 Change-2.21%
Jun-30-17Initiated Cantor Fitzgerald Overweight $70
Apr-27-17Reiterated RBC Capital Mkts Sector Perform $55 → $58
Apr-04-17Upgrade Leerink Partners Mkt Perform → Outperform
Oct-26-16Reiterated RBC Capital Mkts Sector Perform $50 → $55
Oct-13-16Initiated Wells Fargo Outperform
Jul-27-16Reiterated RBC Capital Mkts Sector Perform $47 → $50
Jun-06-16Resumed JP Morgan Neutral
Apr-27-16Reiterated RBC Capital Mkts Sector Perform $40 → $47
Apr-14-16Upgrade Piper Jaffray Neutral → Overweight
Feb-03-16Reiterated RBC Capital Mkts Sector Perform $37 → $40
Nov-16-15Resumed Piper Jaffray Neutral $90 → $39
Aug-11-15Reiterated Barclays Overweight $43 → $45
Jul-30-15Downgrade Leerink Partners Outperform → Mkt Perform $82 → $40
Jul-13-15Reiterated RBC Capital Mkts Sector Perform $74 → $37
Jul-02-15Reiterated Barclays Overweight $80 → $43
Jul-02-15Downgrade BofA/Merrill Buy → Neutral
Jul-01-15Downgrade Credit Suisse Outperform → Neutral $75 → $39
Jun-24-15Initiated Goldman Buy
May-19-15Reiterated Barclays Overweight $83 → $80
Jan-08-15Reiterated RBC Capital Mkts Sector Perform $72 → $76
Jul-26-17 10:21AM  Baxter beats Street 2Q forecasts Associated Press
08:47AM  Baxter International (BAX) Beats on Earnings And Sales in Q2 Zacks
07:15AM  Baxter Reports Second-Quarter 2017 Results and Provides Updated Financial Outlook for 2017 and 2020 Business Wire
Jul-24-17 10:40AM  What to Expect from Baxter Internationals 2Q17 Earnings Market Realist
09:11AM  Discussing Baxter Internationals 2Q17 Revenue Estimates Market Realist
07:41AM  Analysts Views on Baxter International ahead of Its 2Q17 Results Market Realist
Jul-20-17 05:47PM  Abiomed in 2017: The Analysts View Market Realist
03:13PM  U.S. FTC approves Baxter's acquisition of Claris business with condition Reuters
10:00AM  Baxter Releases Annual Corporate Responsibility Report; Announces Progress Toward Social and Environmental 2020 Goals Business Wire
09:48AM  Baxter International (BAX) Q2 Earnings: What's in Store? Zacks
Jul-18-17 08:55AM  Baxter Declares Quarterly Dividend Business Wire
Jul-17-17 04:30PM  Baxter Appoints Cathy R. Smith to Its Board Business Wire
Jul-11-17 05:24PM  3 Excellent Value Picks Amid Political Grind in MedTech Zacks
12:17PM  Baxter Stock Jumps After Positive BMO Note, Then Retreats
11:06AM  Baxter International Climbs On BMO Upgrade
09:30AM featured highlights: Sanderson Farms, American Woodmark, Vertex Pharmaceuticals, Baxter International and A. O. Smith Zacks
Jul-07-17 08:56AM  Baxter and TAU Ink New Licensing Agreements through Ramot Zacks
Jul-06-17 08:00AM  Baxter, Ramot at Tel Aviv University and Tel Aviv Sourasky Medical Center Partner to Bring New Surgical Innovations Worldwide Business Wire
Jun-29-17 04:15PM  Baxter International Inc. to Host Second Quarter 2017 Financial Results Conference Call for Investors Business Wire
Jun-28-17 10:36AM  Baxter Is Focusing on Inorganic Growth Opportunities in 2017 Market Realist
09:06AM  Baxters Integrated Pharma Solutions May Be Solid Growth Driver Market Realist
07:37AM  In-Center Hemodialysis Poses Challenge to Baxters Renal Business Market Realist
Jun-27-17 10:38AM  Baxters Renal Business Continues to Be Key Growth Driver Market Realist
09:09AM  Baxter Expected to Report Significant Fall in Net Profit Margins Market Realist
07:43AM  Baxter Expected to Report Robust Revenue Growth in 2017 Market Realist
Jun-26-17 05:46PM  Analyst Recommendations for Baxter and Peers in June 2017 Market Realist
08:30AM  Baxter Announces DoseEdge Bi-Directional Integration with Epic in the Pharmacy Business Wire
Jun-22-17 09:30AM featured highlights: American Woodmark, Lantheus Holdings, Baxter International, Apogee Enterprises and MAM Software Group Zacks
09:04AM  Baxter (BAX) Scales 52-Week High: What's Behind the Rally Zacks
Jun-16-17 02:35PM  2 Solid Medical Device Stocks to Scoop Up Right Away Zacks
Jun-15-17 09:25AM  Baxter-Dorizoe Ink Deal to Expand Generic Injectables Line Zacks
Jun-14-17 08:30AM  Baxter Announces Agreement with Dorizoe Lifesciences to Further Expand Generic Injectables Pipeline Business Wire
Jun-12-17 07:37AM  How Does Baxter Create Value for Its Shareholders? Market Realist
Jun-09-17 03:35PM  FDA Approval Boosts Baxters Generic Injectable Business Market Realist
02:05PM  Baxter International: Important Highlights in 1Q17 Market Realist
12:12PM  Analysts Latest Recommendations for Baxter International Market Realist
Jun-07-17 11:00AM  Baxter Announces U.S. FDA Approval and Commercial Launch of Ready-to-Use Clindamycin Injection in Saline Business Wire
Jun-05-17 04:05PM  Baxter Presents Data on Telehealths Role in Improving Peritoneal Dialysis Patient Care at ERA-EDTA 2017 Business Wire
08:00AM  New Data Demonstrates High Performance of HDx Enabled by THERANOVA, Baxters Novel Hemodialysis Therapy Business Wire
Jun-02-17 06:41PM  Daniel Loeb's Favorite Idea Spurs May Outperformance
Jun-01-17 11:43AM  Baxter International, Inc. : BAX-US: Dividend Analysis : June 02nd, 2017 (record date) : By the numbers : June 1, 2017 Capital Cube
10:26AM  3 Medical Device Stocks with Solid Potential to Buy Now Zacks
09:00AM  Baxter to Present Significant Data at ERA-EDTA 2017 to Help Advance New Standards of Renal Care Business Wire
May-31-17 09:37AM  Baxter International at a 52-Week High on Solid Product Line Zacks
09:15AM  Baxter and Mayo Clinic Launch Research and Development Collaboration to Transform Patient Care Business Wire
May-30-17 03:13AM  Baxter International (BAX) Up 6.7% Since Earnings Report: Can It Continue? Zacks
May-25-17 04:25PM  Tweedy Browne Sells Baxter, Cisco, 3M
11:29AM  Medtronic's focus on surgical products fuels profit beat Reuters
09:30AM featured highlights: Applied Materials, Coherent, Axcelis Technologies, Baxter International, Ultra Clean Holdings, Kelly Services and Ferro Zacks
May-24-17 03:47PM  Fed balance sheet unwind 'absolutely' reduces chance of more rate hikes: Former Dallas Fed advisor CNBC
10:15AM  New Strong Buy Stocks for May 24th Zacks
May-23-17 03:19PM  Can These 3 High-Flying Healthcare Stocks Reach the Clouds? Motley Fool
12:01PM  Alexion stock plummets 9% after top management shake-up MarketWatch
08:30AM  Baxter Presents Data at ISPOR Annual Meeting with Focus on Helping Hospitals Improve Patient Care Business Wire
May-22-17 09:30AM featured highlights: Baxter International, Lantheus Holdings, OraSure Technologies, MAM Software Group and Teradyne Zacks
08:35AM  Quest Diagnostics Poised on Solid Q1 Results Despite Woes Zacks
May-19-17 11:54AM  Baxter International Inc. -- Moody's rates Baxter's new euro notes Baa2; stable outlook Moody's
10:19AM  Medtronic (MDT) RESOLUTE ONYX Meets Primary Study Endpoint Zacks
10:00AM  Commonwealth Fund President, David Blumenthal, MD, MPP, Named 2017 Recipient of the William B. Graham Prize for Health Services Research Business Wire
May-18-17 04:15PM  Baxter to Present at the Goldman Sachs 38th Annual Healthcare Conference Business Wire
09:25AM  Baxter Launches New AK 98 Hemodialysis System Designed to Help Providers Reach Treatment Goals Business Wire
May-17-17 08:59AM  Edwards Lifesciences SAPIEN 3 Heart Valve Data Positive Zacks
May-16-17 04:04PM  Yum Brands, Intuitive Surgical Called Buys; Pfizer Cut To Sell Investor's Business Daily
09:50AM  New Strong Buy Stocks for May 16th Zacks
May-15-17 08:33AM  TransEnterix (TRXC) Reports Wider-than-Expected Loss in Q1 Zacks
May-12-17 08:50AM  Masimo (MASI) Beats on Q1 Earnings and Revenues, Guides Up Zacks
08:47AM  New Strong Buy Stocks for May 12th Zacks
08:23AM  Medtronic (MDT) Wins FDA Approval for CRT-P SureScan Suite Zacks
08:06AM  STERIS (STE) Grapples with Headwinds: Should You Dump? Zacks
May-11-17 10:15AM  Genomic Health (GHDX) Misses Q1 Earnings & Sales Estimates Zacks
10:07AM  Dull Q1 Earnings & Tough Industry Spell Trouble for BioScrip Zacks
08:59AM  Becton (BDX) Announces $4.5B Follow-On Share Offerings Zacks
May-10-17 09:30AM featured highlights: Cohu, Axcelis Technologies, Insight Enterprises, Baxter International and Ultra Clean Holdings Zacks
09:27AM  STERIS (STE) Tops Q4 Earnings & Revenues, Issues '18 View Zacks
09:18AM  Penumbra (PEN) Q1 Loss Wider than Expected, View Intact Zacks
May-09-17 04:20PM  ETFs with exposure to Baxter International, Inc. : May 9, 2017 Capital Cube
01:43PM  PetMed (PETS) Beats Earnings, Revenue Estimates in Q4 Zacks
11:00AM  Baxter Named One of Americas Best Employers by Forbes Magazine for Third Consecutive Year Business Wire
10:02AM  Henry Schein (HSIC) Tops Q1 Earnings, Reaffirms '17 View Zacks
09:33AM  Haemonetics (HAE) Tops Q4 Earnings, Sales, Issues 2018 View Zacks
09:24AM  New Strong Buy Stocks for May 9th Zacks
07:53AM  Phibro (PAHC) Posts In Line Earnings in Q3, Revises View Zacks
May-08-17 11:14AM  Baxter International, Inc. :BAX-US: Earnings Analysis: Q1, 2017 By the Numbers : May 8, 2017 Capital Cube
10:01AM  Align Technology Invisalign Sales Strong, Currency Woes Stay Zacks
09:47AM  Qiagen Banks on Molecular Diagnostic amid Currency Woes Zacks
09:32AM  CVS Down on Weak Earnings, Pharmacy Services Remains Strong Zacks
09:30AM  VWR Corp (VWR) Beats on Q1 Earnings, Awaits Merger Closure Zacks
May-05-17 10:47AM  BioScrip (BIOS) Q1 Loss Narrower than Expected, Sales Miss Zacks
08:29AM  Omnicell (OMCL) Q1 Loss Narrower than Expected, Revenues Lag Zacks
06:44AM  [$$] Justice Department Investigating Baxter Over Saline Shortage The Wall Street Journal
May-04-17 09:30AM featured highlights: Cott, Rogers, Baxter International, MKS Instruments and CSX Zacks
08:57AM  Cardiovascular Systems (CSII) Swings to Earnings in Q3 Zacks
08:54AM  Bruker (BRKR) Q1 Earnings Meet, Revenues Beat Estimates Zacks
07:59AM  5 Top Efficient Stocks to Boost Your Portfolio Zacks
May-03-17 07:25PM  5 Skyrocketing Stocks On the Move Zacks
12:23PM  5 Companies Reach Yearly Highs
09:06AM  Bet on Relative Price Performance with These 5 Stocks Zacks
08:40AM  Myriad Genetics (MYGN) Tops Q3 Earnings & Sales, Tweaks View Zacks
08:30AM  Baxter Achieves Regulatory Milestone for New Peritoneal Dialysis Technology Business Wire
May-02-17 10:18AM  Dow's Pfizer Tops Earnings Views, But Sales Come Up Short Investor's Business Daily
Baxter International Inc. provides a portfolio of renal and hospital products. The company operates through two segments, Hospital Products and Renal. The Hospital Products segment manufactures intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, parenteral nutrition therapies, infusion pumps, inhalation anesthetics, and biosurgery products. This segment also provides products and services related to pharmacy compounding, drug formulation, and packaging technologies. The Renal segment provides products to treat end-stage renal disease, irreversible kidney failure, and acute kidney therapies. This segment offers products for various treatment continuums, such as technologies and therapies for peritoneal dialysis, hemodialysis, continuous renal replacement therapy, and additional dialysis services. The company sells its products for use in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and by patients at home under physician supervision. It offers its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. The company has a collaboration agreement with JW Holdings Corporation to co-develop and distribute parenteral nutritional products containing a novel formulation of omega 3 lipids; and agreement with Celerity Pharmaceutical, LLC to develop certain acute care generic injectable premix and oncolytic molecules. It also has a strategic partnership with ScinoPharm Taiwan, Ltd. to develop, manufacture, and commercialize five injectable drugs for cancer treatments, such as lung cancer, multiple myeloma, and breast cancer, as well as medication to treat nausea and vomiting, and side effects of chemotherapy. Baxter International Inc. was founded in 1931 and is headquartered in Deerfield, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Third Point LLCDirectorJun 01Sale59.505,000,000297,500,00041,001,790Jun 02 05:13 PM
Shapazian Carole JDirectorMay 23Sale57.922,618151,6359,848May 24 05:00 PM
Shapazian Carole JDirectorMay 09Option Exercise33.773,760126,97516,226May 10 04:16 PM
Shapazian Carole JDirectorMay 09Sale55.893,760210,14612,466May 10 04:16 PM
Eyre Brik VSr VP, President, AmericasMay 08Option Exercise36.71130,7324,799,204176,148May 09 05:16 PM
Eyre Brik VSr VP, President, AmericasMay 08Sale55.69130,7327,280,46545,416May 09 05:16 PM
STALLKAMP THOMAS TDirectorMay 05Option Exercise28.698,080231,82215,593May 09 04:25 PM
STALLKAMP THOMAS TDirectorMay 05Sale55.7610,698596,49011,273May 09 04:25 PM
STROUCKEN ALBERT P LDirectorApr 10Option Exercise30.734,280131,52425,667Apr 12 06:01 PM
STROUCKEN ALBERT P LDirectorApr 10Sale52.804,280225,98421,387Apr 12 06:01 PM
GAVIN JAMES R IIIDirectorMar 29Option Exercise30.734,280131,52434,980Mar 30 04:12 PM
GAVIN JAMES R IIIDirectorMar 29Sale51.724,280221,36230,700Mar 30 04:12 PM
Third Point LLCDirectorFeb 28Sale50.355,901,767297,153,96846,001,790Mar 01 11:25 AM
HELLMAN PETER SDirectorFeb 22Option Exercise30.734,280131,52424,420Feb 23 04:23 PM
HELLMAN PETER SDirectorFeb 22Sale49.814,280213,18720,140Feb 23 04:23 PM
FORSYTH JOHN DDirectorFeb 08Option Exercise30.734,280131,52431,338Feb 10 04:02 PM
FORSYTH JOHN DDirectorFeb 08Sale48.354,280206,93827,058Feb 10 04:02 PM
Shapazian Carole JDirectorFeb 06Option Exercise30.734,280131,52413,507Feb 08 04:14 PM
Shapazian Carole JDirectorFeb 06Sale48.234,280206,4249,227Feb 08 04:14 PM
STORM KORNELIS J.DirectorNov 18Option Exercise30.734,280131,52425,208Nov 22 04:27 PM
STORM KORNELIS J.DirectorNov 18Sale47.104,280201,58820,928Nov 22 04:27 PM